Phio Pharmaceuticals Corp (PHIO) Social Stream



Phio Pharmaceuticals Corp (PHIO): $0.72

0.01 (+1.77%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PHIO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Phio Pharmaceuticals Corp (PHIO) Price Targets From Analysts

Use the tables below to see what analysts covering Phio Pharmaceuticals Corp think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-12 1 $6 $6 $6 $0.874 586.5%

Price Target Last Issued January 12, 2022

The Trend in the Analyst Price Target


PHIO's average price target has moved up $2 over the prior 30 weeks.

Over the past 40 weeks, PHIO's average upside potential has been 177.81%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-17 0 4 4 4 2.29 74.67%
2021-07-10 1 6 6 6 2.08 188.46%
2021-07-17 1 6 6 6 1.82 229.67%
2021-09-04 1 6 6 6 2.03 195.57%
2021-09-11 1 6 6 6 2.05 192.68%

PHIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Phio Pharmaceuticals Corp's number of analysts covering the stock is higher than practically none of them.
  • To contextualize these metrics, consider that out of all US stocks, Phio Pharmaceuticals Corp's variance in analysts' estimates is lower than just about 100% of them.
  • In terms of how Phio Pharmaceuticals Corp fares relative to Healthcare stocks, note that its average analyst price target is greater than 7.49% of that group.
  • In terms of how Phio Pharmaceuticals Corp fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 87.74% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Phio Pharmaceuticals Corp are PCSA, ORGS, and ONCS.

What is the outlook for PHIO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5585 seconds.